A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models
A wearable osmotic microneedle patch with high loading capacity provides sustained drug delivery for 24 hours in small- and large-animal models.
Related Articles
Judge blocks rule that eased U.S. reviews of biotech crops
Some plant researchers fear the setback could last years and will stifle innovation
Genes That Determine Tooth Shape Identified, Including One Inherited from the Neanderthals
Previous studies found that genes inherited from Neanderthals may contribute to greater pain sensitivity and impact the shape of our noses.
Signal Peptide Harnesses Exosomes for Precise Drug Delivery
Exosome Binding Protein (EBP) can be used to direct other proteins to exosomes, effectively allowing for targeted delivery of exosomes and their contents.
Science’s ‘Dance Your Ph.D.’ contest is open again!
This year’s competition has a special category on artificial intelligence research or quantum science—no Ph.D. needed
SSRI Antidepressants May Cause Fewer Side Effects When Targeted to the Gut
Results identify intestinal epithelial 5-HT as a new and potentially safer therapeutic target for mood regulation.
‘Blob’ heat wave killed millions of seabirds—and they haven’t bounced back
Historic 2016 event may have permanently altered northern Pacific ecosystem
Novel Link Between Cell Nutrition and Identity Could Improve Immunotherapies
Metabolic changes influence T cell identity and open avenues for interventions to sustain immune function.
Home | Recycle Health
Recycle Health was started to reduce e-waste and provide activity trackers and smart watches to underserved populations. Recycle Health is a 501(c)3 non-profit organization dedicated…
Accelerating the pace of innovation in robotics by fostering diversity and inclusive leadership
Diverse and inclusive teams are not merely a moral imperative but also a catalyst for scientific excellence in robotics.
Wavegate receives $26M for neuromodulation technology for chronic pain
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.
